The University of Chicago Header Logo

Connection

Lilly Immergluck to Vaccines, Synthetic

This is a "connection" page, showing publications Lilly Immergluck has written about Vaccines, Synthetic.
Connection Strength

0.242
  1. Neutralizing Antibody Immune Correlates for a Recombinant Protein Vaccine in the COVAIL Trial. Clin Infect Dis. 2025 Feb 05; 80(1):223-227.
    View in: PubMed
    Score: 0.242
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.